Luminostix BV

Luminostix commercialises Differential Pathlength Spectroscopy (DPS), a patented optical technology for quantitative measurements in optically diffuse media. Currently the main focus of Luminostix is the field of non invasive diagnosis of superficial cancer. Currently, Luminostix is developing its first medical product. CE-certification and market introduction are expected at the end of 2013. Founded in 2006, Luminostix is a spin-off company from the Center for Optical Diagnosis and Therapy at the Erasmus Medical Center in Rotterdam.

 

Luminostix1
Luminostix2

Luminostix BV
Erasmus MC, Faculty Building Room Ee-1900
Dr. Molewaterplein 50 3015 GE Rotterdam
The Netherlands
Phone: +31 10 7043428
Contact: Dick Sterenborg
info@luminostix.com
http://www.luminostix.com

Levels
  • Manufacturer
  • Application developer
  • Consultant in photonics
Products
  • Other
Markets
  • Health & Wellness
Competences
  • Photonic devices
  • Other